Drug intelligence / Profile preview

Chai Jin Jie Yu An Shen Tablet

Development stage: Unknown
Lead developer: Hunan University of Chinese Medicine
Administration: Oral

Overview

Chai Jin Jie Yu An Shen Tablet is a traditional Chinese medicine (TCM) formulation developed by the Hunan University of Chinese Medicine for the treatment of major depressive disorder (MDD). It is specifically designed for patients presenting with the TCM syndrome of liver-qi stagnation and spleen-deficiency. The formulation is currently being evaluated in a Phase III randomized, double-blind, placebo-controlled, multicenter clinical trial in China. As a TCM product, it likely contains a combination of herbal extracts intended to regulate qi, resolve stagnation, and harmonize the spleen and stomach to alleviate depressive symptoms and improve sleep quality.

Other names: Chai Jin Jie Yu An Shen Pian

Beyond the preview

Go deeper on Chai Jin Jie Yu An Shen Tablet.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chai Jin Jie Yu An Shen Tablet.

Explore the full profile